Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.47 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.47 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.47 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.47 |
| ▸ | F7 | P08709 | 1/20 | 0.44 |
| ▸ | F3 | P13726 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
| ▸ | PPARA | Q07869 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23139471 | 1.00 | CHRNB2 (0.47) | CHRNB2CHRNB4CHRNA3CHRNA4F7 | |
| SCHEMBL16658741 | 0.92 | PPARG (0.51) | F7F3PPARGPPARAPTPN1 | |
| SCHEMBL16658746 | 0.92 | PPARG (0.51) | F7F3PPARGPPARAPTPN1 | |
| SCHEMBL16658747 | 0.92 | PPARG (0.51) | F7F3PPARGPPARAPTPN1 | |
| SCHEMBL8699813 | 0.92 | PPARG (0.51) | F7F3PPARGPPARAPTPN1 | |
| SCHEMBL8699814 | 0.92 | PPARG (0.51) | F7F3PPARGPPARAPTPN1 | |
| SCHEMBL16658744 | 0.92 | PPARG (0.51) | F7F3PPARGPPARAPTPN1 | |
| SCHEMBL16658740 | 0.92 | PPARG (0.51) | F7F3PPARGPPARAPTPN1 | |
| SCHEMBL16658743 | 0.92 | PPARG (0.51) | F7F3PPARGPPARAPTPN1 | |
| Hydrochloric Acid SCHEMBL29067637 | 0.92 | PPARG (0.47) | F7F3PPARGPPARAPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4599890-A2 | SUNITINIB FOR PREVENTING AND/OR TREATING AMYOTROPHIC LATERAL SCLEROSIS | Kyoto University (JP) | 2025-08-13 | — | — | EP | disclosed |
| US-20240358641-A1 | PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE | ALLERGAN, INC. | 2024-10-31 | — | — | US | disclosed |
| US-20240207287-A1 | POLYMERIC IMPLANTS | ALLERGAN INC (US) | 2024-06-27 | — | — | US | disclosed |
| US-20240173236-A1 | Topical Testosterone (T) for Promoting Hair Growth-Containing Formulations | CORBOY JR EDWARD DUNNE (US) | 2024-05-30 | — | — | US | disclosed |
| US-11833238-B2 | Topical testosterone (T) for promoting hair growth-containing formulations | CORBOY JR EDWARD DUNNE (US) | 2023-12-05 | — | — | US | disclosed |
| US-20220087918-A1 | Topical Testosterone (T) for Promoting Hair Growth-Containing Formulations | CORBOY JR EDWARD DUNNE (US) | 2022-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240207287-A1 | POLYMERIC IMPLANTS | PDE6C, PDE6A, PHOSPHO1 | CHRNB2 1467/4885CHRNB4 1548/4885CHRNA3 1519/4885 |
| US-20240358641-A1 | PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE | LIPA, PDE6C, PDE6A | CHRNB2 4131/4885CHRNB4 3858/4885CHRNA3 3891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.